Ads
related to: abbvie pharmaceuticals- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- AbbVie News Center
Search results
Why AbbVie Stock Stumbled Today Despite the Earnings Beat
Motley Fool via Yahoo Finance· 2 days agoThose sales figures would be more than twice the drugs' totals last year. Those are just two of the...
Better Dividend Stock: AbbVie or Johnson & Johnson?
Motley Fool via Yahoo Finance· 20 hours agoLast year, the company earned approval for Epkinly, a new cancer medicine that could reach peak sales of $3 billion in the U.S. alone, according to some...
AbbVie (ABBV) Beats Q1 Earnings and Revenue Estimates
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) delivered earnings and revenue surprises of 2.21% and 2.65%, respectively, for the...
REFILE-AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
Reuters via Yahoo Finance· 4 days ago(Corrects to remove extraneous text and to add Regeneron ticker symbol) April 25 (Reuters) - AbbVie said on Thursday its drug, Rinvoq, for treating a type of inflammatory ...
AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Reuters via AOL· 4 days agoRinvoq helped 19.9% of patients simultaneously achieve near-complete skin clearance with a...
Q1 2024 AbbVie Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 2 days agoScott T. Reents; Executive VP & CFO; AbbVie Inc. Carter Lewis Gould; Senior Analyst; Barclays Bank... Division Luisa Caroline Hector; Co-Head of Global Pharmaceutical ...
AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump
Investopedia· 3 days agoShares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...
AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study By...
Investing.com· 3 days agoAbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
AbbVie's newer drugs are offsetting losses of the world's once best-selling medication
Quartz· 3 days agoSales of the pharma giant's newer drugs are offsetting its Humira losses.
AbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up By Investing.com
Investing.com· 3 days agoAbbVie hikes 2024 earnings guidance as Q1 beat estimates, shares up
Ads
related to: abbvie pharmaceuticals
